559.7000 -16.15 (-2.80%)
NSE Jul 06, 2026 15:45 PM
Volume: 148.7K
 

559.70
-2.80%
Axis Direct
We expect gross margins to be impacted due to an increase in revenue share from the non-regulated market going onwards, therefore recommend HOLD' with a target price of Rs 1,670/share (PE 20x for FY23EPS).
Promoters pledged 5.53% of shares in last quarter. Total pledge stands at 31.57% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended